General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 10.20
-0.25 (-2.39%)
Jul 30, 2026, 1:41 PM CST
General Biologicals Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 215.74 | 215.74 | 251.93 | 264.83 | 370.46 | 551.66 |
Revenue Growth | -14.18% | -14.36% | -4.87% | -28.51% | -32.85% | 15.93% |
Gross Profit Gross Profit Growth | 59.62 | 59.62 | 7.54 | 62.71 | 171.85 | 281.94 |
Operating Income Operating Income Growth | -197.05 | -197.05 | -215.78 | -169.94 | -40.87 | 43.79 |
Net Income Net Income Growth | 465.84 | 465.84 | -220.82 | -198.83 | -53.19 | 44.14 |
Earnings Per Share EPS Growth | 7.44 | 7.44 | -3.69 | -3.32 | -0.89 | 0.74 |
EPS Growth | - | - | - | - | - | -37.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Technology Medical Technology Growth | 43.51 | 43.51 | 70.24 | 158.27 | 129.73 | 182.85 |
Adjustment and Elimination Adjustment and Elimination Growth | -15.16 | -15.16 | -8.12 | -60.29 | -44.57 | -27.44 |
Diagnostic Reagents Diagnostic Reagents Growth | 102.9 | 102.9 | 155.46 | 132.69 | 258.54 | 396.24 |
Protein New Drug Protein New Drug Growth | 54.68 | 54.68 | 34.34 | 34.14 | 26.76 | - |
Lease Management Lease Management Growth | 29.81 | 29.81 | - | - | - | - |
Total Total Growth | 215.74 | 215.74 | 251.93 | 264.83 | 370.46 | 551.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 634.75 | 634.75 | 251.65 | 217.12 | 351.08 | 368.77 |
Total Debt Total Debt Growth | 2,496 | 2,496 | 2,310 | 548.46 | 468.82 | 449.44 |
Net Cash (Debt) Net Cash Growth | -1,862 | -1,862 | -2,058 | -331.34 | -117.74 | -80.66 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -29.74 | -29.74 | -34.40 | -5.54 | -1.97 | -1.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -127.26 | -127.26 | -189.68 | 225.68 | 225.01 | 38.97 |
Capital Expenditures CapEx Growth | -180.02 | -180.02 | -1,545 | -424.02 | -248.42 | -14.73 |
Free Cash Flow Free Cash Flow Growth | -307.28 | -307.28 | -1,735 | -198.33 | -23.42 | 24.24 |
Free Cash Flow Growth | - | - | - | - | - | 3.23% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.63% | 27.63% | 2.99% | 23.68% | 46.39% | 51.11% |
Operating Margin | -91.34% | -91.34% | -85.65% | -64.17% | -11.03% | 7.94% |
Pretax Margin | 234.31% | 234.31% | -88.17% | -70.88% | -12.45% | 7.00% |
Profit Margin | 215.93% | 215.93% | -87.65% | -75.08% | -14.36% | 8.00% |
FCF Margin | -142.43% | -142.43% | -688.57% | -74.89% | -6.32% | 4.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 1.40 | 1.68 | - | - | - | 47.16 |
P/FCF Ratio | - | - | - | - | - | 85.87 |
PS Ratio | 3.43 | 3.62 | 5.06 | 6.10 | 4.34 | 3.77 |